کد مقاله | کد نشریه | سال انتشار | مقاله انگلیسی | نسخه تمام متن |
---|---|---|---|---|
8537134 | 1561006 | 2019 | 46 صفحه PDF | دانلود رایگان |
عنوان انگلیسی مقاله ISI
Ketamine-induced hypnosis and neuroplasticity in mice is associated with disrupted p-MEK/p-ERK sequential activation and sustained upregulation of survival p-FADD in brain cortex: Involvement of GABAA receptor
دانلود مقاله + سفارش ترجمه
دانلود مقاله ISI انگلیسی
رایگان برای ایرانیان
کلمات کلیدی
MDZMKPNF-kBERKLORRMEK-ERKloss of the righting reflexPSD-95KETNF-κBFADDMAPK - MAPKMAPK phosphatase - MAPK فسفاتازMAPK kinase - MAPK کینازγ-aminobutyric acid-A receptor - γ-آمینوآبتیریک اسید-گیرندهElk-1 - الک-1CNS - دستگاه عصبی مرکزیRighting reflex - رفلکس راستcentral nervous system - سیستم عصبی مرکزیNuclear factor-kappa B - فاکتور هسته ای-کاپا BMEK - مجاهدین خلقMouse brain - مغز ماوسMidazolam - میدازولامneurofilament light - نور نورفیلمNeuroplasticity - نوروپلاستیHypnosis - هیپنوتیزمFas-associated protein with death domain - پروتئین مرتبط با Fas با دامنه مرگmitogen-activated protein kinase - پروتئین کیناز فعال با mitogenKetamine - کتامینextracellular signal-regulated kinase - کیناز تنظیم شده سیگنال خارج سلولیGABAA - گابا
موضوعات مرتبط
علوم زیستی و بیوفناوری
علم عصب شناسی
روانپزشکی بیولوژیکی
پیش نمایش صفحه اول مقاله
![عکس صفحه اول مقاله: Ketamine-induced hypnosis and neuroplasticity in mice is associated with disrupted p-MEK/p-ERK sequential activation and sustained upregulation of survival p-FADD in brain cortex: Involvement of GABAA receptor Ketamine-induced hypnosis and neuroplasticity in mice is associated with disrupted p-MEK/p-ERK sequential activation and sustained upregulation of survival p-FADD in brain cortex: Involvement of GABAA receptor](/preview/png/8537134.png)
چکیده انگلیسی
Ketamine (KET) is an antidepressant and hypnotic drug acting as an antagonist at excitatory NMDA glutamate receptors. The working hypothesis postulated that KET-induced sleep in mice results in dysregulation of mitogen-activated protein kinases (MAPK) MEK-ERK sequential phosphorylation and upregulation of survival p-FADD and other neuroplastic markers in brain. Low (5-15â¯mg/kg) and high (150â¯mg/kg) doses of KET on target proteins were assessed by Western immunoblot in mouse brain cortex. During the time course of KET (150â¯mg/kg)-induced sleep (up to 50â¯min) p-MEK was increased (up to +79%) and p-ERK decreased (up to â46%) indicating disruption of MEK to ERK signal. Subhypnotic KET (5-15â¯mg/kg) also revealed uncoupling of p-MEK (+13-81%) to p-ERK (unchanged content). KET did not alter contraregulatory MAPK mechanisms such as inactivated p-MEK1 (ERK dampening) and phosphatases MKP1/2/3 (ERK dephosphorylation). As other relevant findings, KET (5, 15 and 150â¯mg/kg) upregulated p-FADD in a dose-dependent manner, and for the hypnotic dose the effect paralleled the time course of sleep which resulted in increased p-FADD/FADD ratios. KET (150â¯mg/kg) also increased NF-κΠand PSD-95 neuroplastic markers. Flumazenil (a neutral allosteric antagonist at GABAA receptor) prolonged KET sleep and blocked p-MEK upregulation, indicating the involvement of this receptor as a negative modulator. SL-327 (a MEK inhibitor) augmented KET sleep, further indicating the relevance of reduced p-ERK1/2 in KET-induced hypnosis. These findings suggest that hypnotic and subhypnotic doses of KET inducing uncoupling of p-MEK to p-ERK signal and regulation of p-ERK (downregulation) and p-FADD (upregulation) may participate in the expression of some of its adverse effects (e.g. amnesia, dissociative effects).
ناشر
Database: Elsevier - ScienceDirect (ساینس دایرکت)
Journal: Progress in Neuro-Psychopharmacology and Biological Psychiatry - Volume 88, 10 January 2019, Pages 121-131
Journal: Progress in Neuro-Psychopharmacology and Biological Psychiatry - Volume 88, 10 January 2019, Pages 121-131
نویسندگان
Glòria Salort, MarÃa Álvaro-Bartolomé, Jesús A. GarcÃa-Sevilla,